The investment will expand facilities in Pennsylvania and Minnesota to increase production of AI-enabled ultrasound and image-guided therapy systems.
Philips has announced a plan for new investments of more than $150 million in its US manufacturing and research and development (R&D) operations. The initiative is aimed at expanding the production of AI-powered health technology for the US market.
The new investment builds on the company’s existing annual $900 million R&D investment in the US, where it employs nearly 17,000 people across 40 facilities. According to the company, its innovations are used in 90% of hospitals across the country.
Facility Expansions to Boost Production and Add Jobs
The investment plan includes the expansion of Philips’ manufacturing facility in Reedsville, PA, and its Image Guided Therapy facility in Plymouth, MN. The Reedsville site, which currently manufactures transducers, will be expanded to produce AI-enabled ultrasound systems and customize software and configurations for specific clinical applications, including cardiovascular, general, and maternal care.
The Reedsville expansion is expected to add 24,000 square feet of manufacturing space and 40,000 square feet of warehouse space, creating approximately 120 skilled manufacturing jobs. The recently announced expansion of the Plymouth facility includes the construction of a new medtech training center and is expected to create over 150 new jobs.
“The proposed planned expansion of our manufacturing facilities is a demonstration of our deep commitment to the US region,” says Jeff DiLullo, chief region leader for Philips North America, in a release. “Increasing our manufacturing and R&D capabilities will create jobs and accelerate our ability to deliver better care for more people with innovative AI-enabled solutions.”
We Recommend for You:
